UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Cohen Capital Management Inc.

Cohen Capital Management Inc. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 49,942 shares of the healthcare conglomerate’s stock after selling 383 shares during the period. UnitedHealth Group comprises about 4.2% of Cohen Capital Management Inc.’s investment portfolio, making the stock its 4th largest holding. Cohen Capital Management Inc.’s holdings in UnitedHealth Group were worth $25,264,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $30,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth about $37,000. DecisionPoint Financial LLC boosted its position in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares during the period. Highline Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth about $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth about $57,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $465.58 on Friday. The firm has a market cap of $428.46 billion, a P/E ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The business’s 50 day moving average is $519.27 and its 200-day moving average is $560.48.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.83 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research firms have recently weighed in on UNH. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Finally, Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.